Healthcare company-building profile
NCI SBIR Investor Initiatives
National Cancer Institute SBIR Development Center, National Institutes of Health
AcceleratorGovernment or nonprofit acceleratorNonprofitActive
Source-based profile
Program at a Glance
- Program type
- Accelerator
- Program category
- Government or nonprofit accelerator
- Organization
- National Cancer Institute SBIR Development Center, National Institutes of Health
- Organization type
- Nonprofit
- Location
- Rockville, Maryland
- Company stage served
- Not publicly documented
- Cohort or participation model
- Structured investor initiative cycles with published guidance documents; selected NCI SBIR awardees participate in investor forums and partnering programming
- Investment or funding offered
- Yes
- Published investment terms
- Non-dilutive; NCI SBIR/STTR grants and contracts fund the underlying companies, no equity taken by NCI
- Equity or fee model
- No equity
- Clinical or hospital connection
- Not publicly documented
- Application status
- Active
Public description
About the program
NCI's SBIR Development Center runs a suite of investor and commercialization initiatives for NCI-funded small businesses, including investor forums, pitch training and partnering events designed to connect cancer technology companies with venture and strategic capital. These sit alongside NCI's SBIR/STTR funding pathways and I-Corps at NIH participation. Guidance documents describe eligibility and the structured application process for each initiative.
What the program publicly emphasizes
Focus areas and features
OncologyCancer diagnosticsCancer therapeuticsMedical devicesDigital health
- Category: Government or nonprofit accelerator
- Program structure: Structured investor initiative cycles with published guidance documents; selected NCI SBIR awardees participate in investor forums and partnering programming
- Published terms: Non-dilutive; NCI SBIR/STTR grants and contracts fund the underlying companies, no equity taken by NCI
Sources
External source links open in a new tab.